News
OSRH
1.720
-8.51%
-0.160
OSR Holdings Delays Annual Report Filing
TipRanks · 17h ago
Weekly Report: what happened at OSRH last week (0324-0328)?
Weekly Report · 2d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 5d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 6d ago
3 Penny Stocks to Watch Now, 3/27/25
TipRanks · 6d ago
Why Greenland Technologies Shares Are Trading Higher By Around 89%; Here Are 20 Stocks Moving Premarket
Benzinga · 6d ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 6d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 6d ago
Crude Oil Gains Over 1%; Cintas Shares Jump After Q3 Earnings
Benzinga · 6d ago
OSR Holdings Shares Double on Trial Results
Dow Jones · 6d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 03/26 12:11
VAXIMM AG- DECREASED TUMOR SIZE OBSERVED IN RESPONDING PATIENTS
Reuters · 03/26 11:17
OSR HOLDINGS APPOINTS DR. CONSTANCE HÖFER AS CHIEF SCIENTIFIC OFFICER
Reuters · 03/25 11:00
Press Release: OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer
Dow Jones · 03/25 11:00
Weekly Report: what happened at OSRH last week (0317-0321)?
Weekly Report · 03/24 11:43
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 03/19 12:07
Why StoneCo Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket
Benzinga · 03/19 10:08
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 03/18 17:05
Weekly Report: what happened at OSRH last week (0310-0314)?
Weekly Report · 03/17 11:56
Weekly Report: what happened at OSRH last week (0303-0307)?
Weekly Report · 03/10 11:58
More
Webull provides a variety of real-time OSRH stock news. You can receive the latest news about OSR Holdings, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About OSRH
More
OSR Holdings, Inc. is a global healthcare company, dedicated to advancing healthcare outcomes and improving the quality of life for people and their families. The Company is focused on building and developing a portfolio of transformative therapies and healthcare solutions. The Company's operating businesses (through its three wholly owned subsidiaries) include developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases and neurovascular intervention medical device and systems distribution in Korea. The Company has business operations in the United States, Europe and South Korea.